title: Plasma volume expansion from the intravenous glucose tolerance test before and after hip replacement surgery.
abstract: BACKGROUND
  Hyperosmotic glucose is injected intravenously when an intravenous glucose tolerance test (IVGTT) is initiated. The extent and time period of plasma volume expansion that occurs in response to the glucose load has not been studied in the perioperative setting.
  
  
  METHODS
  Twenty-two non-diabetic patients aged between 57 and 76 years (mean 68) underwent an IVGTT, during which 0.3 g/kg of glucose 30% (1 ml/kg) was injected as a bolus over one minute, one day before and two days after hip replacement surgery. Twelve blood samples were collected over 75 minutes from each patient. The turnover of both the exogenous glucose and the injected fluid volume was calculated by means of mass balance and volume kinetic analysis.
  
  
  RESULTS
  The IVGTT raised plasma glucose by 9 mmol/L and the plasma volume by 8%. The extracellular fluid volume increased by 320 (SD 60) ml of which 2/3 could be accounted for in the plasma. The half-life of the exogenous glucose averaged 30 minutes before surgery and 36 minutes postoperatively (P < 0.02). The glucose elimination governed 86% of the decay of the plasma volume expansion, which occurred with a half-life of 12 minutes before to 21 minutes after the surgery (median, P < 0.001).
  
  
  CONCLUSIONS
  Hyperosmotic glucose translocated intracellular water to the plasma volume rather than to the entire extracellular fluid volume. The preferential re-distribution acts to dilute the plasma concentrations used to quantify insulin sensitivity and ß-cell function from an IVGTT. The greater-than-expected plasma dilution lasted longer after than before surgery.
authors: Department of Anesthesia, Faculty of Health Sciences, Linköping University, Linköping, Sweden. r.hahn@telia.com.
authors: Robert G
authors: RG
authors: Hahn
authors: Thomas
authors: T
authors: Nyström
authors: Stefan
authors: S
authors: Ljunggren
mesh_terms: D000368:Aged; D019644:Arthroplasty, Replacement, Hip; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D010953:Plasma Volume / Q000502:physiology*
references: Acta Anaesthesiol Scand. 1987 Oct;31(7):572-8
references: 3318268
references: Res Exp Med (Berl). 1984;184(2):125-30
references: 6382491
references: Anesthesiology. 2002 Jun;96(6):1371-80
references: 12170049
references: Theor Biol Med Model. 2011 May 02;8:12
references: 21535887
references: Br J Anaesth. 2003 May;90(5):600-7
references: 12697587
references: Theor Biol Med Model. 2010 Mar 18;7:9
references: 20298586
references: Am J Physiol. 1979 Jun;236(6):E667-77
references: 443421
references: J Surg Res. 2003 Jul;113(1):6-12
references: 12943804
references: Ann Surg. 1966 Apr;163(4):505-22
references: 5934629
references: Clin Sci (Lond). 2008 Dec;115(12):371-8
references: 18471092
references: Am J Physiol Endocrinol Metab. 2008 Jan;294(1):E15-26
references: 17957034
references: Br J Anaesth. 2004 Apr;92(4):485-92
references: 14977794
references: Diabetes. 1992 Mar;41(3):368-77
references: 1551497
references: Trials. 2012 Jul 02;13:97
references: 22747890
references: Can J Anaesth. 1999 Feb;46(2):133-41
references: 10083993
references: J Hypertens. 1998 Jul;16(7):895-906
references: 9794728
references: Anesthesiology. 2010 Aug;113(2):470-81
references: 20613481
references: Comput Math Methods Med. 2011;2011:965075
references: 21966300
references: Anesth Analg. 2002 Dec;95(6):1547-56, table of contents
references: 12456414